SUNAMACHI-ELEMENTARY
14.12.2020 15:32:18 CET | Business Wire | Press release
The Floating City, a virtual island created within the popular Nintendo Switch game Animal Crossing: New Horizons (ACNH) , is providing elementary schools with a platform for special lessons on the theme of SDGs. Led by the 6th Sunamachi Elementary School in Koto-ku, Tokyo, the initiative kicked off on December 10 with a special open class titled “Special Lessons in ACNH .” Participating children visited The Floating City for an opportunity to learn about environmental issues via the game.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005513/en/
The Floating City is a virtual floating island launched within ACNH on December 8, 2020, with supervision from one co-founder of Blue Frontiers, a sustainable property developer currently working toward the creation of a real-world sustainable floating island in the Southern Hemisphere. The in-game island’s content is designed to boost interest in environmental issues among the younger generation, leveraging gameplay to encourage them to think about the future.
Special Lessons in ACNH at Koto-ku 6th Sunamachi Elementary School, Grade 5
The special open class saw participation from 30 children at Tokyo’s 6th Sunamachi Elementary School. The Floating City within ACNH is home to numerous animals, including some endangered species, and the virtual island also incorporates various activities for fun, guided learning.
Children actively asked questions in the session, which focused on current global environmental issues and was led by fisheries scientist Dr. Hiroaki Chiba, an associate professor at Kitasato University. After the lesson, Dr. Chiba commented, “Learning about the environment through games is a great educational tool which creates an opportunity to think about environmental issues and the future.”
The Floating City lets children experience environmental issues through ACNH
In the special lesson, children experienced The Floating City within ACNH through gameplay, deepening their understanding of environmental issues while visiting the island’s various virtual facilities. They learned about sustainable living on The Floating City, which echoes a real floating island, with a wind farm to create electricity through the power of nature and a restaurant serving dishes prepared only from ingredients grown on the island. The game also provides enjoyable opportunities to experience environmental issues, such as visiting a museum of endangered animals and talking with an African elephant. Children were excited by the fishing and bug-catching activities, and enthralled by the island’s many unique features.
Lesson topics: Global environmental issues and the future of fish
Dr. Hiroaki Chiba joined as a special guest instructor and delivered a lesson on what can be done to resolve current environmental issues and marine pollution. Beginning with an explanation of the serious environmental impacts of rising carbon dioxide levels, he described how Japan’s abundant ocean ecosystem has been disrupted by global warming and the acidification of seawater caused by this greenhouse gas, as well as by overfishing.
Dr. Chiba also raised the pressing issue of ocean plastic pollution, pointing out that the cumulative amount of plastic waste in the world is predicted to exceed 12 billion tons by 2050. These plastics are the source of countless “microplastic” particles that cannot be broken down by waves or ultraviolet rays, and even hold the potential to turn oceans into a plastic “soup” uninhabitable to fish. When asked by the children about fish populations around the world, Dr. Chiba explained that fish numbers are decreasing worldwide due to shrinking habitats for cold-water fish caused by global warming and rising sea temperatures.
Finally, students studied the adverse impacts of environmental damage on humans. They learned what they can do to be more eco-friendly and help prevent marine pollution, including practicing the three R’s (reduce, reuse, recycle) and purchasing ecolabelled products.
About The Floating City and Blue Frontiers
Floating cities are a pioneering sustainability solution whose potential to combat various environmental issues has even seen them discussed by a UN-Habitat roundtable. The rich natural surroundings of this in-game recreation have numerous features designed to help users enjoy learning about sustainability and environmental issues––from the many animals representing endangered species who welcome visitors to the island, to fishing and bug-catching activities that generate a warning when users catch more than they need. The Floating City’s guided learning opportunities even include a museum dedicated to extinct animals and a restaurant with a menu that spotlights disappearing ingredients.
The Floating City was created under the supervision of one co-founder of Blue Frontiers, a company that aims to build an environmentally friendly, sustainable floating island in the near future. Visit https://www.blue-frontiers.com/en/ for more information.
Applying for a special lesson
The Floating City is accepting applications from elementary schools interested in hosting special lessons as described above. If your school would like to participate, please email contact@the-floatingcity.com .
Visiting The Floating City
Lie down in your own in-game bed and enter the Dream Address code (DA-8310-5913-5018) to pay a visit to the island.
What you need to visit The Floating City for an in-game guided tour:
- Nintendo Switch on which to play Animal Crossing: New Horizons
- In-game airport access
- Nintendo Switch Online subscription
- Communicative competence in English or Japanese
What you need to visit The Floating City for a non-guided trip:
- Nintendo Switch on which to play Animal Crossing: New Horizons
- Access to in-game dreaming feature
- Nintendo Switch Online subscription
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005513/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
